Norinchukin Bank’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.7M | Buy |
127,946
+5,650
| +5% | +$1.41M | 0.34% | 49 |
|
|
2025
Q4 | $29.5M | Buy |
122,296
+3,539
| +3% | +$905K | 0.34% | 47 |
|
|
2025
Q3 | $32.5M | Sell |
118,757
-11,358
| -9% | -$3.1M | 0.44% | 38 |
|
|
2025
Q2 | $33.6M | Buy |
130,115
+14,479
| +13% | +$3.45M | 0.5% | 34 |
|
|
2025
Q1 | $25.9M | Buy |
115,636
+7,721
| +7% | +$1.8M | 0.48% | 42 |
|
|
2024
Q4 | $24.7M | Buy |
107,915
+10,313
| +11% | +$2.48M | 0.52% | 39 |
|
|
2024
Q3 | $23.8M | Sell |
97,602
-12,215
| -11% | -$2.73M | 0.56% | 38 |
|
|
2024
Q2 | $21M | Buy |
109,817
+3,791
| +4% | +$769K | 0.6% | 36 |
|
|
2024
Q1 | $21M | Sell |
106,026
-4,494
| -4% | -$823K | 0.63% | 34 |
|
|
2023
Q4 | $19M | Sell |
110,520
-41,717
| -27% | -$6.41M | 0.45% | 37 |
|
|
2023
Q3 | $22.5M | Buy |
152,237
+43,774
| +40% | +$7.91M | 0.53% | 33 |
|
|
2023
Q2 | $23.7M | Buy |
108,463
+7,184
| +7% | +$1.6M | 0.4% | 45 |
|
|
2023
Q1 | $22.2M | Buy |
101,279
+8,985
| +10% | +$1.95M | 0.44% | 37 |
|
|
2022
Q4 | $19.2M | Sell |
92,294
-24,849
| -21% | -$5.46M | 0.41% | 41 |
|
|
2022
Q3 | $25.6M | Sell |
117,143
-438
| -0.4% | -$99.7K | 0.52% | 35 |
|
|
2022
Q2 | $24.6M | Sell |
117,581
-14,372
| -11% | -$3.06M | 0.48% | 36 |
|
|
2022
Q1 | $32M | Sell |
131,953
-5,097
| -4% | -$1.23M | 0.43% | 42 |
|
|
2021
Q4 | $35.7M | Buy |
137,050
+29,554
| +27% | +$7.67M | 0.45% | 37 |
|
|
2021
Q3 | $28.3M | Buy |
107,496
+95,465
| +793% | +$26.1M | 0.39% | 42 |
|
|
2021
Q2 | $2.97M | Sell |
12,031
-35
| -0.3% | -$7.36K | 0.04% | 214 |
|
|
2021
Q1 | $2.34M | Buy |
12,066
+206
| +2% | +$41.3K | 0.03% | 246 |
|
|
2020
Q4 | $2.52M | Sell |
11,860
-286
| -2% | -$57K | 0.04% | 210 |
|
|
2020
Q3 | $2.08M | Buy |
12,146
+166
| +1% | +$30.7K | 0.03% | 228 |
|
|
2020
Q2 | $2.3M | Sell |
11,980
-53
| -0.4% | -$8.67K | 0.04% | 184 |
|
|
2020
Q1 | $1.77M | Sell |
12,033
-6,996
| -37% | -$1.11M | 0.03% | 198 |
|
|
2019
Q4 | $2.95M | Sell |
19,029
-1,716
| -8% | -$247K | 0.04% | 259 |
|
|
2019
Q3 | $2.8M | Buy |
20,745
+542
| +3% | +$71K | 0.04% | 273 |
|
|
2019
Q2 | $2.46M | Sell |
20,203
-6,995
| -26% | -$775K | 0.04% | 289 |
|
|
2019
Q1 | $2.83M | Buy |
27,198
+1,100
| +4% | +$114K | 0.04% | 307 |
|
|
2018
Q4 | $2.97M | Buy |
26,098
+7,740
| +42% | +$829K | 0.04% | 262 |
|
|
2018
Q3 | $2.12M | Buy |
18,358
+1,216
| +7% | +$133K | 0.03% | 305 |
|
|
2018
Q2 | $1.78M | Buy |
17,142
+3,025
| +21% | +$306K | 0.03% | 310 |
|
|
2018
Q1 | $1.39M | Buy |
14,117
+2,182
| +18% | +$206K | 0.02% | 316 |
|
|
2017
Q4 | $1.01M | Buy |
11,935
+761
| +7% | +$62.9K | 0.02% | 393 |
|
|
2017
Q3 | $860K | Buy |
+11,174
| New | +$855K | 0.02% | 401 |
|
Other funds holding RMD
VCM
VPM
DAM
Norinchukin Bank's RMD Position: Q1 2026 in Review
Norinchukin Bank increased its ResMed (RMD) stake by 4.6% in Q1 2026, buying an estimated $1.41M and bringing the position to 127,946 shares worth $28.7M. The position accounts for 0.34% of the portfolio, ranked #49.
Norinchukin Bank first reported a position in RMD in Q3 2017 and has held it in 35 quarters since. The position peaked at $35.7M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Norinchukin Bank held 127,946 shares of ResMed worth $28.7M as of Q1 2026.
- Norinchukin Bank bought 5,650 ResMed shares in Q1 2026, an estimated $1.41M.
- ResMed made up 0.34% of Norinchukin Bank's portfolio in Q1 2026, its #49 holding.
- Norinchukin Bank first reported a position in ResMed in Q3 2017 and has held it in 35 quarters since.
- Norinchukin Bank's ResMed position peaked at $35.7M in Q4 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.